Nifty500 Healthcare stocks list
NSESector44 companies
- P/EPrice to earnings of an index. The index's P/E as the exchange publishes it with the close: its members' market value divided by their profit over the last twelve months, each member counted as the index weighs it. Price to earnings of an index: how it is worked out
- 44.93
- P/BPrice to book of an index. The index's P/B as the exchange publishes it: its members' market value divided by their net worth, the assets they own less everything they owe.
- 5.50
- Dividend yieldDividend yield of an index. The index's dividend yield as the exchange publishes it: dividends its members paid over the last twelve months as a percentage of their market value.
- 0.47%
- 1MOne-month return of an index. The latest close against the close a month earlier, on the same date or the last trading day before it, as a percentage. One-month return of an index in the glossary
- −4.93%
- 3MThree-month return of an index. The latest close against the close three months earlier, on the same date or the last trading day before it, as a percentage. Three-month return of an index in the glossary
- −2.56%
- 1YOne-year return of an index. The latest close against the close a year earlier, on the same date or the last trading day before it, as a percentage. One-year return of an index in the glossary
- +8.27%
P/E against its own past
Where today's P/E sits among every trading day of each window: the dot is today, the tick the middle day.
At or below today's level on 78% of 247 trading days over the last 1 year.
P/E at each month's last trading day, and on 27 Oct 2026
What the Nifty500 Healthcare companies earned
Revenue against the same quarter a year earlier, over today's members that filed both; profit after tax added up over the members that filed the quarter. A quarter fewer than 60% of them filed is left out, and the newest is added once nearly as many have filed it as the one before.
- Revenue growthRevenue growth, against a year earlier. Revenue of the quarter to Jun 2026 against the same quarter a year earlier, added up over the 44 companies that filed both.
- +16.5%quarter to Jun 2026
- ProfitProfit after tax, added up. Profit after tax of the quarter to Jun 2026, added up over the 44 companies that filed it; a loss counts as negative.
- ₹16,281 Crquarter to Jun 2026
- Filed the quarterCompanies that filed the quarter. How many of the index's 44 listed companies have filed results for the quarter to Jun 2026; the revenue growth and the profit are theirs.
- 44of 44
- Median ROCEMedian return on capital employed. The middle figure of the 44 companies' ROCE for the year to Mar 2026, half above and half below. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them.
- 14.9%year to Mar 2026
Revenue against the same quarter a year earlier, per cent
Profit after tax, ₹ crore, added up over the companies that filed
The largest companies
The 12 largest companies in the Nifty500 Healthcare, each sized by its market cap.
Market cap, ₹ crore
- Sun Pharmaceutical Industries₹4,20,172 Cr
- Divi's Laboratories₹2,52,341 Cr
- Torrent Pharmaceuticals₹1,75,920 Cr
- Zydus Lifesciences₹1,16,997 Cr
- Laurus Labs₹1,15,735 Cr
- Apollo Hospitals Enterprise₹1,12,030 Cr
- Dr. Reddy's Laboratories₹1,09,343 Cr
- Cipla₹1,09,063 Cr
- Mankind Pharma₹1,03,365 Cr
- Aurobindo Pharma₹93,643 Cr
- Lupin₹89,263 Cr
- Max Healthcare Institute₹82,245 Cr
Companies in the Nifty500 Healthcare
Largest first, by market cap.Healthcare sector
Sun Pharmaceutical IndustriesSUNPHARMA · Pharmaceuticals & Biotechnology₹1,751.20+0.64%₹4,20,172 Cr34.7016.9%0.91%+3.4%
Divi's LaboratoriesDIVISLAB · Pharmaceuticals & Biotechnology₹9,505.50+5.03%₹2,52,341 Cr86.3020.8%0.32%+46.5%
Torrent PharmaceuticalsTORNTPHARM · Pharmaceuticals & Biotechnology₹4,625.00+1.65%₹1,75,920 Cr82.8012.0%0.82%+28.6%
Zydus LifesciencesZYDUSLIFE · Pharmaceuticals & Biotechnology₹1,172.90+1.08%₹1,16,997 Cr25.9015.9%0.09%+15.7%
Laurus LabsLAURUSLABS · Pharmaceuticals & Biotechnology₹2,142.00+4.04%₹1,15,735 Cr105.9019.8%0.09%+127.8%
Apollo Hospitals EnterpriseAPOLLOHOSP · Healthcare Services₹7,791.50−0.67%₹1,12,030 Cr53.6019.9%0.26%−0.7%
Dr. Reddy's LaboratoriesDRREDDY · Pharmaceuticals & Biotechnology₹1,310.00−0.07%₹1,09,343 Cr39.106.0%0.61%+2.0%
Mankind PharmaMANKIND · Pharmaceuticals & Biotechnology₹2,502.50+8.24%₹1,03,365 Cr46.0013.6%None+3.6%
Aurobindo PharmaAUROPHARMA · Pharmaceuticals & Biotechnology₹1,627.50+2.36%₹93,643 Cr25.2011.5%None+48.7%
Glenmark PharmaceuticalsGLENMARK · Pharmaceuticals & Biotechnology₹2,265.70+1.79%₹63,944 Cr35.6039.8%0.11%+25.0%
Alkem LaboratoriesALKEM · Pharmaceuticals & Biotechnology₹5,078.00+0.95%₹60,715 Cr28.1016.5%1.04%−7.3%
Abbott IndiaABBOTINDIA · Pharmaceuticals & Biotechnology₹25,515.00+1.15%₹54,218 Cr33.6039.6%2.57%−14.3%
IPCA LaboratoriesIPCALAB · Pharmaceuticals & Biotechnology₹1,980.80+2.18%₹50,254 Cr38.4017.6%0.30%+52.6%
Anthem BiosciencesANTHEM · Pharmaceuticals & Biotechnology₹837.15+1.81%₹47,176 Cr81.9021.2%0.24%+14.5%
Ajanta PharmaAJANTPHARM · Pharmaceuticals & Biotechnology₹3,353.60−0.81%₹41,906 Cr36.9027.2%1.79%+40.1%
GlaxoSmithKline PharmaceuticalsGLAXO · Pharmaceuticals & Biotechnology₹2,472.40+1.08%₹41,884 Cr39.2056.3%2.31%−8.0%
Emcure PharmaceuticalsEMCURE · Pharmaceuticals & Biotechnology₹1,875.20+5.34%₹35,575 Cr35.2025.2%0.19%+39.0%
Sai Life SciencesSAILIFE · Pharmaceuticals & Biotechnology₹1,486.20+2.83%₹31,570 Cr87.3018.7%None+69.2%
Acutaas ChemicalsACUTAAS · Pharmaceuticals & Biotechnology₹3,793.30+13.27%₹31,056 Cr70.7030.2%0.07%+119.1%
Krishna Institute of Medical SciencesKIMS · Healthcare Services₹697.65+4.19%₹29,302 Cr143.308.7%None−2.8%
Rubicon ResearchRUBICON · Pharmaceuticals & Biotechnology₹1,509.60+1.30%₹24,989 Cr86.7025.8%0.10%+155.9%
Neuland LaboratoriesNEULANDLAB · Pharmaceuticals & Biotechnology₹19,315.00+1.36%₹24,781 Cr49.8032.1%0.18%+22.3%
Granules IndiaGRANULES · Pharmaceuticals & Biotechnology₹830.55+1.22%₹22,656 Cr34.2015.1%0.21%+46.8%
Cohance LifesciencesCOHANCE · Pharmaceuticals & Biotechnology₹479.25+3.39%₹18,336 Cr172.603.0%None−43.6%
Onesource Specialty PharmaONESOURCE · Pharmaceuticals & Biotechnology₹1,589.80+13.78%₹18,231 Cr–0.8%None−12.1%
Caplin Point LaboratoriesCAPLIPOINT · Pharmaceuticals & Biotechnology₹2,352.40+3.45%₹17,881 Cr26.9019.8%0.34%+16.7%
Concord BiotechCONCORDBIO · Pharmaceuticals & Biotechnology₹1,375.30+4.89%₹14,388 Cr50.9015.9%0.55%−5.7%
Rainbow Childrens MedicareRAINBOW · Healthcare Services₹1,198.20+3.12%₹12,170 Cr42.6025.0%0.29%−11.9%
Funds that follow the Nifty500 Healthcare
1 index fund or ETF tracks the Nifty500 Healthcare.
Mirae Asset Nifty 500 Healthcare ETFETF · Mirae Asset Mutual FundNAV₹20.77281Y–3Y–5Y–Size₹14 CrCost0.35%
About the Nifty500 Healthcare
Nifty500 Healthcare tracks healthcare stocks drawn from the Nifty 500, up to the 50 largest by free-float market capitalisation. It is maintained by NSE Indices Limited. Free float is the share of a company's shares that is available for trading.
How companies are chosen
Only stocks in the Nifty 500 at the time of review are eligible, and only those in the basic industries that represent the healthcare sector. These include pharmaceuticals, biotechnology, hospitals, healthcare service providers, medical equipment and supplies, pharmacy retail, and healthcare research, analytics and technology. The list may be updated from time to time.
The index takes the 50 largest eligible stocks by six-month average free-float market capitalisation. Stocks that trade in NSE's futures and options (F&O) segment are picked first. Non-F&O stocks fill any remaining places. The index holds at least 10 stocks where enough qualify.
A stock outside both the index and F&O is ineligible if, over the past 6 months to the cut-off date, it hit the upper or lower price limit on at least 20% of trading days. Hitting both limits on one day counts twice.
How it is weighted
Each stock is weighted by its free-float market capitalisation, and no single stock may exceed 10%. The cap is applied on the last trading day of Mar, Jun, Sep and Dec. Between those dates weights drift with prices.
When it is reviewed
The index is reconstituted twice a year, in Mar and Sep, using data for the six months ended Jan and Jul. A stock that leaves the Nifty 500 also leaves this index at the next review. An F&O stock outside the index replaces the smallest member outside F&O. Any other newcomer needs a free-float market capitalisation at least 1.5 times that of the smallest member of its kind, F&O or not. Extra changes follow a deletion from the Nifty 500, a suspension, a delisting or a scheme of arrangement.
Base date and value
The index has a base date of 1 Apr 2005 and a base value of 1000. It was launched on 25 Jun 2025.
- Published by
- NSE
- Kind
- Sector
- CompaniesCompanies in an index. How many companies the index holds on its current list, which the exchange revises from time to time. Companies in an index in the glossary
- 44
- List last changed
- 9 Oct 2026
- Above 200-day averageMembers above their 200-day average. The share of the index's members whose latest close is above their own average close of the last 200 trading days; members listed too recently to have one are left out. Members above their 200-day average in the glossary
- 27 of 44
Sector indices
Others in this group, the most used as a fund's benchmark first.All
BSE Auto21 companiesP/E 31.36
BSE Capital Goods34 companiesP/E 45.79- BSE Capital Markets23 companiesP/E 37.95
BSE Commodities211 companiesP/E 18.92
BSE Consumer Discretionary409 companiesP/E 48.36
BSE Consumer Durables10 companiesP/E 53.99- BSE Energy37 companiesP/E 11.91
BSE Fast Moving Consumer Goods114 companiesP/E 30.10
BSE Focused IT14 companiesP/E 21.53- BSE Housing Finance11 companiesP/E 25.04